Related Experiment Video
Updated: Jul 9, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells
Yoko Mikami-Terao1, Masaharu Akiyama, Yuki Yuza
1Department of Pediatrics and Institute of DNA Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan.
Cancer Letters
|December 22, 2007
Summary
The anticancer drug TMPyP4 inhibits leukemia cell growth by stabilizing DNA guanine-quadruplexes. This leads to cell cycle arrest and programmed cell death, offering a new strategy for antileukemic therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cationic porphyrin TMPyP4 binds and stabilizes DNA guanine-quadruplexes.
- Leukemia treatment remains a significant challenge in oncology.
Purpose of the Study:
- To investigate the molecular mechanism of TMPyP4's antitumor activity.
- To explore TMPyP4's effects on K562 cells and hTERT-transfected K562 cells with enhanced telomerase activity.
Main Methods:
- Cell growth inhibition assays.
- Cell cycle analysis (G1, S, G2/M phases).
- cDNA microarray analysis, Western blotting, and kinase activation assays.
Main Results:
- 100 μM TMPyP4 significantly inhibited leukemia cell growth.
- TMPyP4 induced G1 arrest and increased S and G2/M phase cells, preceding cell death.
- Gene expression changes, decreased c-Myc, increased p21(CIP1)/p57(KIP2), and activated MAP kinases (p38, JNK, ERK) were observed.
Conclusions:
- TMPyP4 exhibits significant antitumor activity against leukemia cells.
- The mechanism involves DNA guanine-quadruplex stabilization, cell cycle modulation, and kinase pathway activation.
- Guanine-quadruplex-interactive agents like TMPyP4 show promise for novel antileukemic therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...